Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPolar Capital Regulatory News (POLR)

Share Price Information for Polar Capital (POLR)

Share Price is delayed by 15 minutes
Get Live Data
820.00    -11.00 (-1.32%)
Bid:
816.00
Ask:
822.00
Spread: 6.00 (0.735%)
Market Cap: £774.61m
POLR Live PriceLast checked at - London Stock Exchange

Intraday Polar Capital Share Chart

AUM Update

12 Oct 2017 07:00

RNS Number : 3732T
Polar Capital Holdings PLC
12 October 2017
 

12 October 2017

Polar Capital Holdings plc

AUM Update

 

Polar Capital Holdings plc ("Polar Capital" or the "Group"), the specialist asset management group, today provides its regular quarterly update of its unaudited statement of its Assets under Management ("AUM").

 

 

Group AUM (unaudited)

 

Polar Capital reports that as at 30 September 2017 its AUM were £10.6bn compared to £9.3bn at the end of March 2017.

 

AUM movement in six months to 30 September 2017

Long only

funds

Alternative funds

Total

AUM at

31 March 2017

£8,447m

£826m

£9,273m

Net subscriptions

/ (redemptions)

£656m

£164m

£820m

Market movement

and performance

£494m

£16m

£510m

Total AUM at

30 September 2017

£9,597m

£1,006m

£10,603m

 

 

Net performance fees (unaudited)

 

The table below sets out the position relating to net performance fee profits due to the Group (after the deduction of staff interests) as a product of accrued performance fees in funds managed by the Group three months before the strike point of such performance fee receipts. The majority of the Group's performance fees crystallise in the second half of the financial year.

 

Performance fees

net of staff allocations

Six months to

30 Sept 16

 

 

Year to

31 Mar 17

(year-end)

 

Six months to

30 Sept 17

 

 

Received

 

£0.0m

£1.2m

£0.0m

Accrued but not yet earned in funds with year ends on or before the financial year end

£2.8m

n/a

£9.6m

Total net performance fees

£2.8m

£1.2m

 

£9.6m

 

 

 

Comment

 

The Group has had a satisfactory quarter, in terms of both performance and flows.

 

As is usual at the time of releasing this update, three months before the crystallisation of performance fees, we disclose the profits that could be due to Polar as a function of the amount of accrued performance fees in our funds as at the end of September. Although there is no certainty that the fees will be sustained over the next quarter, the quantum of net performance fee receipts is a marked improvement on the position of twelve months ago; the figure reflects the pleasing performance of the Group's funds - the key driver of the business.

 

It is also gratifying to report another quarter of positive net inflows with over £350m received in the quarter following our first quarter of over £450m of net inflows. The flows this quarter were seen across a number of strategies including: our two UK strategies, Technology, Healthcare, Insurance, Income Opportunities and European Income. The current quarter has started in an encouraging fashion following the successful launch of the Automation and Artificial Intelligence Fund.

 

The Group now has a funding requirement for its Long-Term Incentive Plan ("LTIP") and believes that buying stock in the market on behalf of the Employee Benefit Trust ("EBT") is an efficient way to ameliorate the dilutive effects of issuing shares. The Group continues to enjoy a strong balance sheet and capital position and therefore wishes the market to be aware that in future it may use the buyback authority granted it by shareholders at the Group's Annual General Meeting.

 

For further information please contact:

 

Polar Capital

Gavin Rochussen (Chief Executive)

John Mansell (COO)

+44 (0)20 7227 2700

 

Canaccord Genuity - Nomad and Joint Broker

Simon Bridges (QE)

Andrew Buchanan

 

+44 (0)20 7523 8000

 

 

Peel Hunt - Joint Broker

Guy Wiehahn

 

+44 (0)20 7418 8893

 

Camarco

Ed Gascoigne-Pees

 

 

+44 (0)20 3757 4984

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
UPDEAKEFFSAXFFF
Date   Source Headline
4th Feb 20199:43 amRNSBlock listing Interim Review
1st Feb 201911:41 amRNSTotal Voting Rights
29th Jan 20194:41 pmRNSSecond Price Monitoring Extn
29th Jan 20194:35 pmRNSPrice Monitoring Extension
28th Jan 20195:45 pmRNSIssue of Equity
28th Jan 20195:30 pmRNSDirector/PDMR Shareholding
10th Jan 201910:19 amRNSDirector/PDMR Shareholding
10th Jan 20197:00 amRNSAUM Update
2nd Jan 20199:49 amRNSTotal Voting Rights
12th Dec 20184:00 pmRNSIssue of Equity
27th Nov 20184:40 pmRNSSecond Price Monitoring Extn
27th Nov 20184:35 pmRNSPrice Monitoring Extension
26th Nov 20187:00 amRNSUnaudited Interim Results
22nd Nov 20185:00 pmRNSDirectorate Change
5th Nov 20187:01 amRNSNotice of Results
5th Nov 20187:00 amRNSChange of Nominated Adviser and Broker
1st Nov 20187:00 amRNSTotal Voting Rights
25th Oct 20185:26 pmRNSIssue of Equity
24th Oct 20184:52 pmRNSDirector/PDMR Shareholding
17th Oct 20185:49 pmRNSIssue of Equity
15th Oct 201812:38 pmRNSForm 8.3 - Jardine Lloyd Thompson Group Plc
12th Oct 20182:52 pmRNSForm 8.3 - Jardine Lloyd Thompson Group Plc
11th Oct 20184:42 pmRNSIssue of Equity
11th Oct 20187:01 amRNSCrystallisation of business unit & issue of shares
11th Oct 20187:00 amRNSAUM Update
3rd Oct 201810:24 amRNSForm 8.3 - Jardine Lloyd Thompson Group Plc
19th Sep 201811:52 amRNSForm 8.3 - Jardine Lloyd Thompson Group
18th Sep 201812:02 pmRNSForm 8.3 - Realm Therapeutics PLC
17th Aug 20189:27 amRNSDirectorate Change
6th Aug 20187:00 amRNSBlock listing Interim Review
1st Aug 20187:00 amRNSTotal Voting Rights
31st Jul 20185:57 pmRNSIssue of Equity
31st Jul 201811:29 amRNSDirector/PDMR Shareholding
25th Jul 20183:38 pmRNSDirectorate Change
25th Jul 20183:26 pmRNSResult of AGM
19th Jul 201811:13 amRNSForm 8.3 - Consort Medical Plc
18th Jul 20184:21 pmRNSDirector/PDMR Shareholding
18th Jul 201811:50 amRNSForm 8.3 - Consort Medical Plc
17th Jul 201810:58 amRNSForm 8.3 - Consort Medical Plc
16th Jul 20183:44 pmRNSDirector/PDMR Shareholding
12th Jul 201811:50 amRNSForm 8.3 - Consort Medical Plc
12th Jul 20187:00 amRNSAuM Update
11th Jul 201811:06 amRNSForm 8.3 - Consort Medical Plc
3rd Jul 20186:27 pmRNSHolding(s) in Company
3rd Jul 20186:20 pmRNSIssue of Equity
3rd Jul 201812:07 pmRNSForm 8.3 - Consort Medical Plc
2nd Jul 201810:23 amRNSTotal Voting Rights
29th Jun 20187:00 amRNSBlock Listing Application
28th Jun 20185:55 pmRNSAnnual Financial Report
25th Jun 20187:00 amRNSGroup Audited Results for year ended 31 March 2018

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.